newsfilter
← Latest News
GlobeNewswire·

Registration Is Now Open For Tribe Public's CEO Presentation and Q&A Webinar Event

  • Serina Therapeutics CEO Steven Ledger will present at Tribe Public's webinar titled "Navigating the New FDA Era: 2026 Strategic Priorities and the Future of Life Sciences" on Wednesday, February 4, 2026.
  • The event begins at 8:30 am Pacific / 11:30 am Eastern 2026.
  • Participants may register for the complimentary event at New-FDA-Era.TribePublic.com.
  • Questions for the CEO can be submitted via email to research@tribepublic.com or through the ZOOM chat feature during the session.
  • Tribe Public Managing Member John F. Heerdink, Jr. will host the event relay questions to management.
  • Serina Therapeutics is a clinical-stage biotechnology company headquartered in Huntsville, Alabama, developing its proprietary POZ Platform for neurological diseases.
  • The POZ Platform aims to improve efficacy safety profiles for small molecules, RNA-based therapeutics, antibody-based drug conjugates.
  • The press release includes a cautionary statement regarding forward-looking statements about FDA clinical holds, clinical program timing, the potential of the POZ polymer technology.
  • Actual results may differ materially due to risks including regulatory approval timelines, clinical trial outcomes, commercial success factors.
  • Stefan Riley is the contact for inquiries at sriley@serinatherapeutics.com or (256) 327-9630.